Dr. Eric A. Rose has demonstrated significant management of his stock holdings in SIGA Technologies. Between 2019 and 2024, his insider trading reported values fluctuated extensively, peaking at $22.39 million in August 2022. This high point shows a strong investor...
Dr. Eric A. Rose has demonstrated significant management of his stock holdings in SIGA Technologies. Between 2019 and 2024, his insider trading reported values fluctuated extensively, peaking at $22.39 million in August 2022. This high point shows a strong investor confidence during a critical period for the company. Over the years, his holdings have seen exciting movements, from around $5.73 million in late 2019 to impressive highs, but have also come down as of late 2024, indicating the volatility and potential of biotech investments. His involvement in the stock market reflects a keen insight into the company’s performance and its future prospects. Throughout the years, he maintained a strategic outlook on his trades reflecting his understanding of the biopharmaceutical industry.